About
Our Approach
Our Team
SCN Service Program
SCN Ambassador
Government Procurement
New Patients: Start Here
Ketamine
Ketamine Therapy
Depression
Anxiety
PTSD
OCD
Suicidal Ideation
Chronic Pain
Post-Op & Injury
Migraine
Long-COVID
Investment
Our Process
TMS Therapy
Our Process
Your Investment
ONE-D Protocol
Resources
Research and Resources
FAQs
Our Blog
Testimonials
Providers
For Providers
Patient Referral
Skip to content
Confused by psychedelic therapy hype? Charles Miller’s publication shows what really matters: lasting mental health through brain rewiring. Click here to read more.
About
Our Approach
Our Team
SCN Service Program
SCN Ambassador
Government Procurement
New Patients: Start Here
Ketamine
Ketamine Therapy
Depression
Anxiety
PTSD
OCD
Suicidal Ideation
Chronic Pain
Post-Op & Injury
Migraine
Long-COVID
Investment
Our Process
TMS Therapy
Our Process
Your Investment
ONE-D Protocol
Resources
Research and Resources
FAQs
Our Blog
Testimonials
Providers
For Providers
Patient Referral
About
Our Approach
Our Team
SCN Service Program
SCN Ambassador
Government Procurement
New Patients: Start Here
Ketamine
Ketamine Therapy
Depression
Anxiety
PTSD
OCD
Suicidal Ideation
Chronic Pain
Post-Op & Injury
Migraine
Long-COVID
Investment
Our Process
TMS Therapy
Our Process
Your Investment
ONE-D Protocol
Resources
Research and Resources
FAQs
Our Blog
Testimonials
Providers
For Providers
Patient Referral
Request Consultation
(423) 228-0579
About
Our Approach
Our Team
SCN Service Program
SCN Ambassador
Government Procurement
New Patients: Start Here
Ketamine
Ketamine Therapy
Depression
Anxiety
PTSD
OCD
Suicidal Ideation
Chronic Pain
Post-Op & Injury
Migraine
Long-COVID
Investment
Our Process
TMS Therapy
Our Process
Your Investment
ONE-D Protocol
Resources
Research and Resources
FAQs
Our Blog
Testimonials
Providers
For Providers
Patient Referral
About
Our Approach
Our Team
SCN Service Program
SCN Ambassador
Government Procurement
New Patients: Start Here
Ketamine
Ketamine Therapy
Depression
Anxiety
PTSD
OCD
Suicidal Ideation
Chronic Pain
Post-Op & Injury
Migraine
Long-COVID
Investment
Our Process
TMS Therapy
Our Process
Your Investment
ONE-D Protocol
Resources
Research and Resources
FAQs
Our Blog
Testimonials
Providers
For Providers
Patient Referral
Request Consultation
423.228.0579
How Does Ketamine Infusion Therapy Differ from Antidepressant Therapy?
Charles Miller - Founder/Owner/CRNA
Prev
Previous
What is Minimally Stimulated Ketamine Infusion Therapy (MSKIT
®
)?
Next
ScenicCity Neurotherapy’s Approach to Optimizing Mental Health
Next
Our Post
What Will You Do to Move Forward?
Addressing Chronic Neuropathic Pain with Non-Opioid Therapies at Scenic City Neurotherapy
At-Home Ketamine Therapy Dangers: In-Depth Insights
The Science Behind Transcranial Magnetic Stimulation (TMS) Therapy: Life After Treatment
“Psychedelic Medicine” Needs A Rebrand: Acknowledging the Potential of Psychoplastogenic Medicine
Scroll Up